|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
2009-10-16
|
|
pubmed:abstractText |
To describe the Worldwide-Schizophrenia Outpatient Health Outcomes (W-SOHO) patient population at study entry, focusing on illness burden and prescribing practices across regions.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
1742-1241
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
63
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1578-88
|
|
pubmed:meshHeading |
pubmed-meshheading:19780867-Adult,
pubmed-meshheading:19780867-Ambulatory Care,
pubmed-meshheading:19780867-Antipsychotic Agents,
pubmed-meshheading:19780867-Female,
pubmed-meshheading:19780867-Humans,
pubmed-meshheading:19780867-Male,
pubmed-meshheading:19780867-Prospective Studies,
pubmed-meshheading:19780867-Rural Health,
pubmed-meshheading:19780867-Schizophrenia,
pubmed-meshheading:19780867-Treatment Outcome,
pubmed-meshheading:19780867-Urban Health
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Worldwide-Schizophrenia Outpatient Health Outcomes (W-SOHO): baseline characteristics of pan-regional observational data from more than 17,000 patients.
|
|
pubmed:affiliation |
Clinical Research, Eli Lilly Canada Inc., Toronto, ON, Canada M1N 2E8. karagianis_jamie@lilly.com
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
